Pterygium Recurrence in a Private Eye Clinic in Abuja

A. C. Okudo; O.E. Babalola

Authors

A. C. Okudo Rachel Eye Center, Abuja, Nigeria
O.E. Babalola Rachel Eye Center, Abuja, Nigeria

Keywords:

Risk factors, Conjunctival autograft, 5 florouracil, Recurrence, Pterygium

Abstract

Background: The major concern following pterygium surgery is recurrence. The study aims to compare the recurrence rate between
5florouracil and conjunctival autograft and the risk factors for recurrence.

Methods: This was a retrospective study carried out in Rachel Eye Center, Abuja, over a 5-year period. The clinical records were obtained from the operation and patients case notes. Information retrieved included demographic characteristics, type of surgery, recurrence and duration of recurrence. Data was analysed using the descriptive, compare means and logistic regression analysis functions of SPSS version 20 Chicago, IL, USA.

Author Biography

O.E. Babalola , Rachel Eye Center, Abuja, Nigeria

College of Medical and Health Sciences, Bingham University Jos/Karu , Nigeria

References

Onwasigwe EN, Ezegwui IR. An overview of management of pterygium in Nigeria. International Journal of Ophthalmology.(2006). 6. 552-554.

Onnebune E, Sarimiye TF, Bekibele C, Ashaye A. Pterygium Surgeries at a Tertiary Hospital, Southwest Nigeria: A Four-Year Review. Niger

J Ophthalmol 2020. 28 ( 1) 18-20

Bekibele, C., Baiyeroju, A., Olusanya, B. et al. Pterygium treatment using 5-FU as adjuvant treatment compared to conjunctiva autograft. Eye 22, 31–34 (2008). https://doi.org/10.1038/sj.eye.6702480

Olusanya BA, Ogun OA, Bekibele CO, Ashaye AO, Baiyeroju AM, Fasina O, Ogundipe AO, Ibrahim AO. Risk factors for pterygium recurrence after surgical excision with combined conjunctival autograft (CAG) and intraoperative antimetabolite use. Afr J Med Med Sci. 2014 Mar;43(1):35-40. PMID: 25335376.